← Weight Loss & Metabolic

Tirzepatide Microdose

The same tirzepatide and B12 vial as Tirzepatide/B12, taken at a much smaller dose (5 units twice weekly) for people who want to ease in.

Dr. Jonathan Snipes, MDMedically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 6, 2026.
Tirzepatide Microdose dispensed by a licensed U.S. 503A compounding pharmacy

Verify us before you order

Which tirzepatide is right for me?

All 3 have the same active ingredient. They differ in what it is compounded with and how much you take. Your provider reviews the choice before anything is prescribed.

Gentle MicrodoseDual-Pathway ActionFewer Side EffectsCompounded with B12

What It Is

This is compounded tirzepatide, not pure tirzepatide. A licensed U.S. 503A compounding pharmacy compounds it as tirzepatide co-formulated with cyanocobalamin (vitamin B12) in the same vial, so every injection contains both. Tirzepatide is a dual GIP/GLP-1 receptor agonist, the same active ingredient as Mounjaro® and Zepbound®. It is the identical vial we prescribe as Tirzepatide/B12, just drawn at a much smaller dose, so the vial lasts longer than standard dosing.

How It Works

By activating both GIP and GLP-1 receptors, tirzepatide supports appetite control and metabolic regulation. At microdose levels the effect is milder and slower, which suits people who want to ease in or who are side-effect sensitive. The B12 is a carrier that supports energy levels during weight loss. It does not change how tirzepatide works and does not add to weight loss on its own.

Who It's For

Adults who want a gentle entry to dual-pathway GLP-1 therapy, are sensitive to side effects, or are microdosing for appetite and metabolic support alongside diet and exercise. Not for patients with a known B12 sensitivity, who should ask their provider about the B6/glycine formulation instead.

Who Should Avoid It

Same as semaglutide: avoid with thyroid cancer history, MEN2, pancreatitis, gastroparesis, or pregnancy. Also avoid if you have reacted to cyanocobalamin (B12), since it is compounded into this vial.

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.


Tirzepatide Microdose Side Effects

Compounded tirzepatide is not FDA approved and has no trials of its own. The numbers below come from the FDA label for Zepbound®, the brand-name tirzepatide taken once a week, in adults treated for weight loss. Our dosing is twice a week, so use them as a guide.

The microdose is below the lowest dose in this table, and the Zepbound® label does not report side effects at doses that low.

Most common side effects

Percent of people in each group, Zepbound® once weekly versus placebo.
Side effectPlacebo5 mg10 mg15 mg
Nausea8%25%29%28%
Diarrhea8%19%21%23%
Vomiting2%8%11%13%
Constipation5%17%14%11%
Stomach pain (abdominal pain)5%9%9%10%
Indigestion (dyspepsia)4%9%9%10%
Injection site reactions2%6%8%8%
Tiredness (fatigue)3%5%6%7%
Allergic reactions (hypersensitivity)3%5%5%5%
Burping (eructation)1%4%5%5%
Hair loss1%5%4%5%
Acid reflux (GERD)2%4%4%5%

Serious risks on the label

  • Thyroid C-cell tumors: tirzepatide caused them in rats, and it is unknown whether it does in people. Do not use it if you or a family member has had medullary thyroid cancer, or if you have MEN 2 (boxed warning).
  • Severe stomach and bowel side effects.
  • Kidney injury from dehydration after nausea, vomiting or diarrhea.
  • Gallbladder problems.
  • Pancreatitis (an inflamed pancreas).
  • Serious allergic reactions.
  • Low blood sugar. The risk is higher with insulin or a medicine that makes the body release more insulin, such as a sulfonylurea.
  • Worsening diabetic eye disease in people with type 2 diabetes.
  • Food or liquid getting into the lungs during anesthesia or deep sedation. Tell the care team about it before any procedure.

Tell your provider about any of these in your health screening. Your provider reviews your history before anything is prescribed.

Source: Zepbound (tirzepatide) prescribing information, Revised 8/2026, Table 1, adults with obesity or overweight in Studies 1 and 2; section 5 and the boxed warning.

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.


Protocol & Pricing

Pharmacy Price

$36/12mg

You pay pharmacy price. No markup.

Starting Dose

5 units twice weekly (0.3mg per injection, 0.6mg per week)

Form

Injectable vial (2mL, 6mg/mL, 12mg total. Compounded tirzepatide + B12, not pure tirzepatide)


Dosing Protocol

5 units subcutaneous injection twice weekly, 3 to 4 days apart. 5 units = 0.05mL × 6mg/mL = 0.3mg per injection (0.6mg per week). Your provider may step the dose up every 4 weeks as tolerated. Hold or step back dose if nausea. Hydration & protein mitigate side effects.

Beyond Use Date

90 Days from compounding (USP <797>)

A licensed U.S. 503A compounding pharmacy assigns this date and prints it on your vial label. Always follow the label.

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.


Stacking Guide

Do Not Combine With

Tirzepatide/B12Tirzepatide/B6 + GlycineSemaglutide/B12Semaglutide/B6 + GlycineSemaglutide Microdose

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.


Independently tested

Tirzepatide Microdose certificate of analysis

All 6 Tirzepatide Microdose samples tested for sterility and endotoxin passed both. Latest sample received by the lab Oct 15, 2026.

Every Tirzepatide Microdose batch dispensed by a licensed U.S. 503A compounding pharmacy is independently tested by Eagle Analytical Services (FDA-registered, A2LA ISO 17025 accredited). Sterility testing checks that nothing grows in the sample; the USP <85> endotoxin test checks for bacterial toxins that can cause fever. Below is the lab's own report for each of the 5 most recent lots.

Lot lg342011354, received Oct 15, 2026

Sterility
PassScanRDI Sterility Test. Started Oct 15, 2026, completed Oct 16, 2026. Method suitability ETX-260302-0448
Bacterial endotoxin
PassUSP <85>. Measured <2 EU/mL, limit 700 EU/mL. Started Oct 16, 2026, completed Oct 16, 2026
Sample, as printed
TIRZEPATIDE/ B12 6 MG/ 500 MCG/ML (2 ML) Injection
Lot #
lg342011354
Storage
Refrigerated
Received by lab
Oct 15, 2026
Laboratory
Eagle Analytical Services Inc., Houston, TX
Submission #
ETX-261015-0452
Signed
Alison Eng, Quality Control Manager
Scan of Eagle Analytical report ETX-261015-0452 for lot lg342011354. Opens the original PDF.
Eagle Analytical report ETX-261015-0452. Open the original PDF (opens in a new tab)

View all 7 Tirzepatide Microdose lab reports

Eagle Analytical Services is an independent FDA-registered laboratory, A2LA accredited to ISO 17025, based in Houston, Texas. They have no commercial relationship with Rx Peps Direct. Rx Peps Direct prescribes; the pharmacy compounds and dispenses; Eagle tests every batch. Three separate companies. Results apply only to the tested sample as received. Browse our full quality program on the quality page.

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.


How to get Tirzepatide Microdose prescribed online

Tirzepatide Microdose is available by prescription after an online medical review and dispensed for human use by a licensed 503A pharmacy. That is what separates it from research-use-only vials sold without a prescription. There is no membership, just a medical review fee per order, and automatic refills are optional.

  1. 1

    Complete a $39 medical review. Answer a short intake about your health history and your goals for Tirzepatide Microdose. The $39 fee is the only charge Rx Peps Direct collects, paid once, not a recurring subscription.

  2. 2

    A licensed provider reviews it. A US-licensed clinician reviews your intake and, if Tirzepatide Microdose is appropriate for you, writes a patient-specific prescription. The starting dose is typically 5 units twice weekly (0.3mg per injection, 0.6mg per week).

  3. 3

    The pharmacy compounds and ships it. A licensed 503A compounding pharmacy in Texas compounds Tirzepatide Microdose and ships it pre-reconstituted by FedEx overnight in a reusable cooled case. Your fill is Injectable vial (2mL, 6mg/mL, 12mg total. Compounded tirzepatide + B12, not pure tirzepatide), and you pay the pharmacy $36/12mg at wholesale, with no clinic markup, plus a $15 flat FedEx overnight shipping fee charged by the pharmacy.

Rx Peps Direct prescribes Tirzepatide Microdose in the 28 states plus Washington, DC where its medical team is licensed. Start your $39 medical review or browse all peptides for weight loss. Comparing services first? See how Rx Peps Direct stacks up against seven other providers in our best telehealth for compounded peptides comparison.

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.


Common questions about Tirzepatide Microdose

What is in the Tirzepatide Microdose vial?
Each vial contains compounded tirzepatide co-formulated with cyanocobalamin (vitamin B12), suspended together in the same solution. It is not pure tirzepatide and it is not a research-use vial. The pharmacy compounds it under a 503A patient-specific prescription, and the label lists both ingredients. The vial is 2 mL at 6 mg/mL (12 mg total) for $36, plus a flat $39 medical review. Every batch is tested by Eagle Analytical Services for sterility and bacterial endotoxin (USP <85>); the Certificate of Analysis is published on this page.
Is this pure tirzepatide?
No. This is a compounded medication, which means the pharmacy prepares tirzepatide together with vitamin B12 in one vial rather than dispensing the tirzepatide molecule on its own. Anyone selling a vial labeled pure tirzepatide for human use outside a compounding pharmacy is selling a research-use product without a prescription. The tirzepatide in this vial is the same active ingredient as Mounjaro and Zepbound, and the B12 does not change how it binds the GIP and GLP-1 receptors.
How is this different from the standard Tirzepatide/B12 vial?
It is the same vial. Same pharmacy, same 6 mg/mL concentration, same 12 mg total, same $36 price. The only difference is the dose your provider writes: the microdose protocol starts at 5 units (0.3 mg) twice weekly, about 0.6 mg per week, where the standard protocol starts at 25 units (1.5 mg) twice weekly. Because you draw less per injection, a single vial lasts considerably longer.
Why is vitamin B12 in a weight loss injection?
Cyanocobalamin acts as a soluble carrier in the formulation and doubles as an energy-supporting cofactor for patients in a caloric deficit. B12 supports red blood cell production and methylation pathways that come under load during fat loss. It is pharmacologically inert with respect to weight loss, so it does not add to your results and it does not change tirzepatide's pharmacology. The B12 carrier is a formulation choice by a licensed U.S. 503A compounding pharmacy, not by Rx Peps Direct.
What if I cannot tolerate B12?
Tell your provider during the intake. Patients with a documented B12 sensitivity, an MTHFR methylation variant, or a history of reacting to cyanocobalamin should ask about the Tirzepatide/B6 + Glycine formulation instead, which uses glycine and vitamin B6 as the carrier and contains no B12. It is the same tirzepatide active ingredient. Do not order this microdose vial if you have reacted to B12 before.
What is the starting dose for the tirzepatide microdose protocol?
5 units on a U-100 insulin syringe, injected subcutaneously twice weekly, 3 to 4 days apart. On the 6 mg/mL vial, 5 units equals 0.05 mL, which is 0.3 mg per injection or 0.6 mg per week. For comparison, the standard Rx Peps Direct protocol is 1.5 mg twice weekly and branded Zepbound starts at 2.5 mg once weekly. Your provider confirms or adjusts the units at review and may step the dose up every 4 weeks as tolerated. Always verify the concentration printed on your vial before drawing.
How long does a microdose vial last?
At the 5 unit starting dose, a 12 mg vial holds far more than the standard protocol would use, but the Beyond Use Date governs how long you can actually use it. The BUD is 90 days from compounding under USP <797> sterile compounding standards and is printed on every vial label. Once opened, keep the vial in the fridge and use it until it is empty or it reaches the date printed on its label, whichever comes first. Refrigerate at 36 to 46 degrees Fahrenheit and do not freeze. Discard at the BUD even if solution remains.

Ready to add Tirzepatide Microdose?

A licensed provider reviews every order.